"Genome-wide association studies (GWAS) have been pivotal to increasing our understanding of intestinal disease. However, the mode by which genetic variation results in phenotypic change remains large
The Peptide Drugs for Intestinal Diseases report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends and
The Enteric Disease Testing Treatment report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows
We report the results of RNA-Seq on iPSCs, Definitive Endoderm (DE), Spheroids (Sph), and induced human intestinal organoids (iHIOs) from colitic and normal primary patient colon tissues
